Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Kirsty on +44 1494 818034 or kirstym@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Kirsty Morris
Senior Account Manager
kirstym@zenopa.com
+44 1494 818034

Testimonials
I have recently had the pleasure of dealing with Zenopa's pharmaceutical recruitment team. I just wanted to let you know how supportive.
Agatha, 2013

Boston Scientific stent now available in Europe and US

7 October 2009 00:00 in Medical Company Product News


Boston Scientific has announced that three models of its WallFlex Biliary RX Covered Stents are now available in both Europe and the US.

All types - fully covered, partially covered and uncovered ? can now be marketed for the palliative treatment of malignant bile duct strictures.

Additional changes have been made to the WallFlex Biliary RX Stent based on research findings and feedback, as it now comes with a platinum-cored Nitinol construction designed to deliver radial force, flexibility and radiopacity.

Michael Phalen, president of the firm's endoscopy operations, said: "Boston Scientific continues to fulfill our promise to deliver industry-leading, innovative technologies that enable physicians to best diagnose and treat digestive diseases and enhance quality of life for patients."

According to the results of a trial involving the company's TAXUS Liberte Stent last month, the updated version of the equipment outperforms its older counterpart when it comes to dealing with small vessels and long coronary lesions.

Other news stories from 07/10/2009

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd